サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530910

注射ドラッグデリバリー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2034年

Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 263 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
注射ドラッグデリバリー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2034年
出版日: 2024年06月14日
発行: Transparency Market Research
ページ情報: 英文 263 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

注射ドラッグデリバリー市場-調査範囲

TMRの調査レポート「注射ドラッグデリバリーの世界市場」は、2024～2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018～2034年までの世界の注射ドラッグデリバリー市場の収益と予測を提供しています。また、2024～2034年までの世界の注射ドラッグデリバリー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、注射ドラッグデリバリー市場を推察しました。

市場スナップショット
2023年の市場規模 6,895億米ドル
2034年の市場規模 1兆9,000億米ドル
CAGR 9.8%

当レポートでは、世界の注射ドラッグデリバリー市場の競合情勢について調査しています。世界の注射ドラッグデリバリー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の注射ドラッグデリバリー市場における参入企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020～2034年

第5章 主要洞察

  • PEST分析
  • 製品の発売と承認
  • 主要地域/国における規制状況
  • FDA医薬品承認プロセス
  • 主要な業界イベント（買収、パートナーシップ、コラボレーション）

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主要調査結果/ 進展
  • 市場金額予測：製品タイプ別、2020～2034年
    • デバイス
      • 従来の注射装置
      • 自己注射器
      • その他
    • 処方
      • 従来のドラッグデリバリー製剤
      • 新しいドラッグデリバリー製剤
      • 持続性のある注射剤
  • 製品タイプ別の市場の魅力

第7章 世界の市場分析と予測：治療用途別

  • イントロダクションと定義
  • 主要調査結果/ 進展
  • 市場金額予測：治療用途別、2020～2034年
    • 自己免疫疾患
    • ホルモン疾患
    • 希少疾患
    • がん
    • 心血管疾患
    • 感染症
    • その他
  • 治療用途別の市場の魅力

第8章 世界の市場分析と予測：利用パターン別

  • イントロダクションと定義
  • 主要調査結果/ 進展
  • 市場金額予測：利用パターン別、2020～2034年
    • 治療ケア
    • 免疫
    • その他
  • 利用パターン別の市場の魅力

第9章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主要調査結果/ 進展
  • 市場金額予測：エンドユーザー別、2020～2034年
    • 病院とクリニック
    • 外来手術センター
    • 在宅医療
    • その他
  • エンドユーザー別の市場の魅力

第10章 世界の市場分析と予測：地域別

  • 主要調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第11章 北米の市場分析と予測

  • 米国
  • カナダ

第12章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州

第13章 アジア太平洋の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他のアジア太平洋

第14章 ラテンアメリカ市場分析と予測

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ

第15章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析企業別（2021年）
  • 市場フットプリント分析
    • By Product Type
  • 競争的ビジネス戦略
  • 企業プロファイル
    • 市場企業-競合マトリックス（企業階層と規模別）
    • 市場シェア分析：企業別（2023年）
    • 企業プロファイル
図表

List of Tables

  • Table 01: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 02: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 03: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 04: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 05: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 06: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 07: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 08: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 09: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 10: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 11: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 12: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 13: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 14: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 15: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 16: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 17: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 18: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 19: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 20: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 21: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 22: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 24: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 25: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 26: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 27: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 28: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 29: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 30: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 31: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 32: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 33: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 34: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 35: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 36: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 37: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 38: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 39: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 40: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 41: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 42: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Injectable Drug Delivery Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global Injectable Drug Delivery Market Value Share, by Product Type, 2023
  • Figure 03: Global Injectable Drug Delivery Market Value Share, by Therapeutic Application, 2023
  • Figure 04: Global Injectable Drug Delivery Market Value Share, by Usage Pattern, 2023
  • Figure 05: Global Injectable Drug Delivery Market Value Share, by End-user, 2023
  • Figure 06: Global Injectable Drug Delivery Market Value Share, by Region, 2023
  • Figure 07: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 08: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2023
  • Figure 09: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2034
  • Figure 10: Global Injectable Drug Delivery Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 11: Global Injectable Drug Delivery Market Value (US$ Bn), by Devices Product Type, 2020-2034
  • Figure 12: Global Injectable Drug Delivery Market Value Share Analysis, by Devices Product Type, 2023 and 2034
  • Figure 13: Global Injectable Drug Delivery Market Value (US$ Bn), by Formulations Product Type, 2020-2034
  • Figure 14: Global Injectable Drug Delivery Market Value Share Analysis, by Formulations Product Type, 2023 and 2034
  • Figure 15: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Therapeutic Application, 2023 and 2034
  • Figure 16: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2023
  • Figure 17: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2034
  • Figure 18: Global Injectable Drug Delivery Market Attractiveness Analysis, by Therapeutic Application, 2024-2034
  • Figure 19: Global Injectable Drug Delivery Market Value (US$ Bn), by Autoimmune Disease, 2020-2034
  • Figure 20: Global Injectable Drug Delivery Market Value Share Analysis, by Autoimmune Disease, 2023 and 2034
  • Figure 21: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
  • Figure 22: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
  • Figure 23: Global Injectable Drug Delivery Market Value (US$ Bn), by Orphan Disease, 2020-2034
  • Figure 24: Global Injectable Drug Delivery Market Value Share Analysis, by Orphan Disease, 2023 and 2034
  • Figure 25: Global Injectable Drug Delivery Market Value (US$ Bn), by Cancer, 2020-2034
  • Figure 26: Global Injectable Drug Delivery Market Value Share Analysis, by Cancer, 2023 and 2034
  • Figure 27: Global Injectable Drug Delivery Market Value (US$ Bn), by Cardiovascular Disease, 2020-2034
  • Figure 28: Global Injectable Drug Delivery Market Value Share Analysis, by Cardiovascular Disease, 2023 and 2034
  • Figure 29: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Infectious Disease, 2023 and 2034
  • Figure 30: Global Injectable Drug Delivery Market Value Share Analysis, by Infectious Disease, 2023 and 2034
  • Figure 31: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Others, 2023 and 2034
  • Figure 32: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 33: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Usage Pattern, 2023 and 2034
  • Figure 34: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2023
  • Figure 35: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2034
  • Figure 36: Global Injectable Drug Delivery Market Attractiveness Analysis, by Usage Pattern, 2024-2034
  • Figure 37: Global Injectable Drug Delivery Market Value (US$ Bn), by Curative Care, 2020-2034
  • Figure 38: Global Injectable Drug Delivery Market Value Share Analysis, by Curative Care, 2023 and 2034
  • Figure 39: Global Injectable Drug Delivery Market Value (US$ Bn), by Immunization, 2020-2034
  • Figure 40: Global Injectable Drug Delivery Market Value Share Analysis, by Immunization, 2023 and 2034
  • Figure 41: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
  • Figure 42: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 43: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 44: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2023
  • Figure 45: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2034
  • Figure 46: Global Injectable Drug Delivery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 47: Global Injectable Drug Delivery Market Value (US$ Bn), by Hospitals and Clinics, 2020-2034
  • Figure 48: Global Injectable Drug Delivery Market Value Share Analysis, by Hospitals and Clinics, 2023 and 2034
  • Figure 49: Global Injectable Drug Delivery Market Value (US$ Bn), by Ambulatory Surgical Centers, 2020-2034
  • Figure 50: Global Injectable Drug Delivery Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034
  • Figure 51: Global Injectable Drug Delivery Market Value (US$ Bn), by Home Care Settings, 2020-2034
  • Figure 52: Global Injectable Drug Delivery Market Value Share Analysis, by Home Care Settings, 2023 and 2034
  • Figure 53: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
  • Figure 54: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 55: Global Injectable Drug Delivery Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 56: Global Injectable Drug Delivery Market Share Analysis, by Region, 2023
  • Figure 57: Global Injectable Drug Delivery Market Share Analysis, by Region, 2034
  • Figure 58: Global Injectable Drug Delivery Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 59: North America Injectable Drug Delivery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 60: North America Injectable Drug Delivery Market Attractiveness Analysis, by Country, 2024-2034
目次
Product Code: TMRGL1336

Injectable Drug Delivery Market - Scope of Report

TMR's report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.

Market Snapshot
Market Value in 2023US$ 689.5 Bn
Market Value in 2034US$ 1.9 Trn
CAGR9.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.

The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.

Key Questions Answered in Global injectable drug delivery Market Report:

  • What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
  • What are the opportunities in the global injectable drug delivery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Injectable Drug Delivery Market - Research Objectives and Research Approach

The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Injectable Drug Delivery Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. PEST Analysis
  • 5.2. Product Launches and Approvals
  • 5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
  • 5.4. FDA Drug Approval Process
  • 5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)

6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2034
    • 6.3.1. Devices
      • 6.3.1.1. Conventional Injection Devices
      • 6.3.1.2. Self Injection Devices
      • 6.3.1.3. Others
    • 6.3.2. Formulations
      • 6.3.2.1. Conventional Drug Delivery Formulations
      • 6.3.2.2. Novel Drug Delivery Formulations
      • 6.3.2.3. Long Lasting Injection Formulations
  • 6.4. Market Attractiveness By Product Type

7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 7.3.1. Autoimmune Disease
    • 7.3.2. Hormone Disease
    • 7.3.3. Orphan Disease
    • 7.3.4. Cancer
    • 7.3.5. Cardiovascular Disease
    • 7.3.6. Infectious Disease
    • 7.3.7. Others
  • 7.4. Market Attractiveness By Therapeutic Application

8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Usage Pattern, 2020-2034
    • 8.3.1. Curative Care
    • 8.3.2. Immunization
    • 8.3.3. Others
  • 8.4. Market Attractiveness By Usage Pattern

9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Home Care Settings
    • 9.3.4. Others
  • 9.4. Market Attractiveness By End-user

10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Injectable Drug Delivery Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2034
    • 11.2.1. Devices
      • 11.2.1.1. Conventional Injection Devices
      • 11.2.1.2. Self Injection Devices
      • 11.2.1.3. Others
    • 11.2.2. Formulations
      • 11.2.2.1. Conventional Drug Delivery Formulations
      • 11.2.2.2. Novel Drug Delivery Formulations
      • 11.2.2.3. Long Lasting Injection Formulations
  • 11.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 11.3.1. Autoimmune Disease
    • 11.3.2. Hormone Disease
    • 11.3.3. Orphan Disease
    • 11.3.4. Cancer
    • 11.3.5. Cardiovascular Disease
    • 11.3.6. Infectious Disease
    • 11.3.7. Others
  • 11.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 11.4.1. Curative Care
    • 11.4.2. Immunization
    • 11.4.3. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Home Care Settings
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Therapeutic Application
    • 11.7.3. By Usage Pattern
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Injectable Drug Delivery Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2034
    • 12.2.1. Devices
      • 12.2.1.1. Conventional Injection Devices
      • 12.2.1.2. Self Injection Devices
      • 12.2.1.3. Others
    • 12.2.2. Formulations
      • 12.2.2.1. Conventional Drug Delivery Formulations
      • 12.2.2.2. Novel Drug Delivery Formulations
      • 12.2.2.3. Long Lasting Injection Formulations
  • 12.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 12.3.1. Autoimmune Disease
    • 12.3.2. Hormone Disease
    • 12.3.3. Orphan Disease
    • 12.3.4. Cancer
    • 12.3.5. Cardiovascular Disease
    • 12.3.6. Infectious Disease
    • 12.3.7. Others
  • 12.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 12.4.1. Curative Care
    • 12.4.2. Immunization
    • 12.4.3. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Home Care Settings
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Therapeutic Application
    • 12.7.3. By Usage Pattern
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2034
    • 13.2.1. Devices
      • 13.2.1.1. Conventional Injection Devices
      • 13.2.1.2. Self Injection Devices
      • 13.2.1.3. Others
    • 13.2.2. Formulations
      • 13.2.2.1. Conventional Drug Delivery Formulations
      • 13.2.2.2. Novel Drug Delivery Formulations
      • 13.2.2.3. Long Lasting Injection Formulations
  • 13.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 13.3.1. Autoimmune Disease
    • 13.3.2. Hormone Disease
    • 13.3.3. Orphan Disease
    • 13.3.4. Cancer
    • 13.3.5. Cardiovascular Disease
    • 13.3.6. Infectious Disease
    • 13.3.7. Others
  • 13.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 13.4.1. Curative Care
    • 13.4.2. Immunization
    • 13.4.3. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Home Care Settings
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Therapeutic Application
    • 13.7.3. By Usage Pattern
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Injectable Drug Delivery Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2034
    • 14.2.1. Devices
      • 14.2.1.1. Conventional Injection Devices
      • 14.2.1.2. Self Injection Devices
      • 14.2.1.3. Others
    • 14.2.2. Formulations
      • 14.2.2.1. Conventional Drug Delivery Formulations
      • 14.2.2.2. Novel Drug Delivery Formulations
      • 14.2.2.3. Long Lasting Injection Formulations
  • 14.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 14.3.1. Autoimmune Disease
    • 14.3.2. Hormone Disease
    • 14.3.3. Orphan Disease
    • 14.3.4. Cancer
    • 14.3.5. Cardiovascular Disease
    • 14.3.6. Infectious Disease
    • 14.3.7. Others
  • 14.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 14.4.1. Curative Care
    • 14.4.2. Immunization
    • 14.4.3. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Home Care Settings
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Therapeutic Application
    • 14.7.3. By Usage Pattern
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2020-2034
    • 15.2.1. Devices
      • 15.2.1.1. Conventional Injection Devices
      • 15.2.1.2. Self Injection Devices
      • 15.2.1.3. Others
    • 15.2.2. Formulations
      • 15.2.2.1. Conventional Drug Delivery Formulations
      • 15.2.2.2. Novel Drug Delivery Formulations
      • 15.2.2.3. Long Lasting Injection Formulations
  • 15.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 15.3.1. Autoimmune Disease
    • 15.3.2. Hormone Disease
    • 15.3.3. Orphan Disease
    • 15.3.4. Cancer
    • 15.3.5. Cardiovascular Disease
    • 15.3.6. Infectious Disease
    • 15.3.7. Others
  • 15.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 15.4.1. Curative Care
    • 15.4.2. Immunization
    • 15.4.3. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Ambulatory Surgical Centers
    • 15.5.3. Home Care Settings
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Therapeutic Application
    • 15.7.3. By Usage Pattern
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Market Footprint Analysis
    • 16.3.1. By Region
    • 16.3.2. By Product Type
  • 16.4. Competitive Business Strategies
  • 16.5. Company Profiles
    • 16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    • 16.5.2. Market Share Analysis, by Company (2023)
    • 16.5.3. Company Profiles
      • 16.5.3.1. Becton, Dickinson, and Company (BD)
        • 16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.1.2. Product Portfolio
        • 16.5.3.1.3. Financial Overview
        • 16.5.3.1.4. SWOT Analysis
        • 16.5.3.1.5. Strategic Overview
      • 16.5.3.2. Pfizer, Inc.
        • 16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.2.2. Product Portfolio
        • 16.5.3.2.3. Financial Overview
        • 16.5.3.2.4. SWOT Analysis
        • 16.5.3.2.5. Strategic Overview
      • 16.5.3.3. Eli Lilly and Company
        • 16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.3.2. Product Portfolio
        • 16.5.3.3.3. Financial Overview
        • 16.5.3.3.4. SWOT Analysis
        • 16.5.3.3.5. Strategic Overview
      • 16.5.3.4. Baxter International, Inc.
        • 16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.4.2. Product Portfolio
        • 16.5.3.4.3. Financial Overview
        • 16.5.3.4.4. SWOT Analysis
        • 16.5.3.4.5. Strategic Overview
      • 16.5.3.5. Terumo Corporation
        • 16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.5.2. Product Portfolio
        • 16.5.3.5.3. Financial Overview
        • 16.5.3.5.4. SWOT Analysis
        • 16.5.3.5.5. Strategic Overview
      • 16.5.3.6. B. Braun Melsungen AG
        • 16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.6.2. Product Portfolio
        • 16.5.3.6.3. Financial Overview
        • 16.5.3.6.4. SWOT Analysis
        • 16.5.3.6.5. Strategic Overview
      • 16.5.3.7. Ypsomed AG
        • 16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.7.2. Product Portfolio
        • 16.5.3.7.3. Financial Overview
        • 16.5.3.7.4. SWOT Analysis
        • 16.5.3.7.5. Strategic Overview
      • 16.5.3.8. Gerresheimer AG
        • 16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.8.2. Product Portfolio
        • 16.5.3.8.3. Financial Overview
        • 16.5.3.8.4. SWOT Analysis
        • 16.5.3.8.5. Strategic Overview
      • 16.5.3.9. SCHOTT Pharma
        • 16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.9.2. Product Portfolio
        • 16.5.3.9.3. Financial Overview
        • 16.5.3.9.4. SWOT Analysis
        • 16.5.3.9.5. Strategic Overview
      • 16.5.3.10. Hi-Tech Syringes
        • 16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.10.2. Product Portfolio
        • 16.5.3.10.3. Financial Overview
        • 16.5.3.10.4. SWOT Analysis
        • 16.5.3.10.5. Strategic Overview